News

From idea to commercialisation – EVENT POSTPONED to Wednesday 4th November 2020

Date: 04.11.2020 Location: Bio-Technopark Schlieren-Zurich, Auditorium, Wagistrasse 25, 8952 Schlieren Organized by: - European Patent Academy - Swiss Federal Institute of Intellectual Property Description: - Why can IP support my business? - What can be patented in the Biotech area? - How can SMEs implement an IP strategy? The roadshow provides answers to these questions by specialists in business...

read more

Swiss Nordic Bio 2020

TIME AND PLACE? Thursday, 6 February 2020, 08:00 – 18:00 @ Radisson Hotel Airport, Zurich, Switzerland WHAT IS SWISS NORDIC BIO? Swiss Nordic Bio is an investor and partnering conference connecting leading Nordic and Swiss healthcare companies with European investors. For more information about the event please visit www.swissnordicbio.com or contact us. WHAT IS...

read more

Molecular Partners Presents Updated Results of MP0250 in Patients with Relapsed/Refractory Multiple Myeloma (MM) at American Society of Hematology Annual Meeting

Zurich-Schlieren, Switzerland, December 7, 2019. Molecular Partners AG (SIX: MOLN), a clinical-stage biotech company pioneering the use of DARPin® therapeutics to treat serious diseases, today announced a poster presentation at the American Society of Hematology 61st Annual Meeting in Orlando, FL, highlighting the activity of its tri-specific DARPin® drug candidate, MP0250, in patients undergoing...

read more

Regulatory Journey – Neun Workshops bringen Sie weiter

Donnerstag, 16. Januar 2020 14.00 bis 20.00 Uhr Startup Space by IFJ Institut für Jungunternehmen AG Wiesenstrasse 5, 8952 Schlieren Workshops: Development Documentation: Best Practices Ein erfolgreicher klinischer Produktlebenszyklus: die PMCF-Strategie Semantic Discovery & AI als Lösungsansatz in der Regulation Journey Aus der Praxis: Wie kann ich mein Produkt einfach CE-zertifizieren? «Outsourced QMS»...

read more